John M Lachin
What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
Herman W, Braffett B, Kuo S, Lee J, Brändle M, Jacobson A, Prosser L, Lachin J. What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?. J Diabetes Complicat 2018; 32:911-915.
12.06.2018What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
12.06.2018J Diabetes Complicat 2018; 32:911-915
Herman William H, Braffett Barbara H, Kuo Shihchen, Lee Joyce M, Brändle Michael, Jacobson Alan M, Prosser Lisa A, Lachin John M
The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
Herman W, Braffett B, Kuo S, Lee J, Brändle M, Jacobson A, Prosser L, Lachin J. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC). J Diabetes Complicat 2018; 32:934-939.
12.06.2018The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
12.06.2018J Diabetes Complicat 2018; 32:934-939
Herman William H, Braffett Barbara H, Kuo Shihchen, Lee Joyce M, Brändle Michael, Jacobson Alan M, Prosser Lisa A, Lachin John M
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program
Hernan W, Brändle M, Zhang P, Williamson D, Matulik M, Ratner R, Lachin J, Engelgau M, Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes care 2003; 26:36-47.
01.01.2003Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program
01.01.2003Diabetes care 2003; 26:36-47
Hernan William H, Brändle Michael, Zhang Ping, Williamson David F, Matulik Margaret J, Ratner Robert E, Lachin John M, Engelgau Michael M, Diabetes Prevention Program Research Group